Ohanna Kirakosyan
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Effect of smoking on drug-resistant tuberculosis treatment outcomes and potential mechanistic pathways: a multicountry cohort study.
Journal: BMJ open respiratory research
Published: September 04, 2025
Effect of smoking on drug-resistant tuberculosis treatment outcomes and exploring potential pathways: A multicountry cohort study.
Journal: medRxiv : the preprint server for health sciences
Published: September 02, 2025
Rehabilitation for individuals with post-tuberculosis lung disease.
Journal: Breathe (Sheffield, England)
Published: August 19, 2025
Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: March 29, 2025
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.
Journal: The New England journal of medicine
Published: January 29, 2025
Effectiveness of a bedaquiline, linezolid, clofazimine 'core' for multidrug-resistant TB.
Journal: IJTLD open
Published: October 02, 2024
Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in Europe.
Journal: IJTLD open
Published: September 23, 2024
Effectiveness of a bedaquiline, linezolid, clofazimine "core" for multidrug-resistant tuberculosis.
Journal: medRxiv : the preprint server for health sciences
Published: January 31, 2024
Integrating hepatitis C treatment into multidrug-resistant TB care.
Journal: Public health action
Published: January 05, 2022
Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 25, 2021
Concomitant Treatment of Chronic Hepatitis C With Direct-Acting Antivirals and Multidrug-Resistant Tuberculosis Is Effective and Safe.
Journal: Open forum infectious diseases
Published: October 28, 2020
Management of patients with multidrug-resistant tuberculosis.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: July 19, 2019
Last Updated: 09/26/2026